Navigation Links
China Kangtai Cactus Biotech Inc. Launches Cactus Cattle Feed and Cactus Fish Feed
Date:7/14/2008

New Products Expected to Increase Annual Sales by 14.4 Million RMB

HARBIN, China, July 14 /Xinhua-PRNewswire-FirstCall/ -- China Kangtai Cactus Biotech Inc. (the "Company") (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based consumer products in China, announced today that it has launched two innovative products, Cactus Cattle Feed and Cactus Fish Feed. It is expected that the Company will generate approximately 14.4 million RMB ($2.1 million) in annual sales from the two products, commencing during the current quarter.

''We believe the market for these products is substantial,'' said Jinjiang Wang, President of China Kangtai Cactus. ''Farmers and other owners of cattle are constantly seeking ways to improve the health and productivity of their livestock and fish, and these products have demonstrated the ability to enhance both. We expect there to be significant interest in each product.''

The products provide cattle with the nutrition from cactus and have characteristics designed to prevent against sepsis, inflammatory illnesses and to boost immunity. The products, which the Company has been developing since 2003, have been included in the National Spark Program of China in May 2004 and obtained the certification of the Chinese Scientific and Technological Achievements.

Test results from the products have been impressive. For example the test of Cactus Cattle Feed increased the milk production of cows while the test of Cactus Fish Feed demonstrated an increased production from fish. Tests have also demonstrated that Cactus Cattle Feed can enhance the ability of animals to against severe colds and can boost the immune system of animals.

The Company obtained patent protection for the two products earlier this year through the issuance of the Certificate of National Invention Patent of China.

About China Kangtai Cactus Biotech, Inc.

China Kangtai Cactus Biotech Inc. is market-leading cactus grower and producer of cactus-related products with over 387 acres of plants and an active R&D group that holds 17 product patents and is seeking another 13 in a variety of product categories. China Kangtai's high-quality products are sold throughout China in supermarkets, food stores, hotels and restaurants through a growing distribution network that has currently covered 12 provinces and 2 municipalities.

Cautionary Statement Regarding Forward-looking Information

This press release contains forward-looking information about China Kangtai Cactus Biotech that is intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology, and include discussions of strategy, and statements about industry trends and China Kangtai Cactus Biotech future performance, operations and products.

For more information, please contact:

Chengzhi Wang

General Manager

China Kangtai Cactus Biotech, Inc.

Tel: +86-158-0451-2893

Email: chinakangtai@gmail.com

Web: http://www.biocactus.com

Investor Relations:

Dan Schustack

CEOcast, Inc.

Tel: +1-212-732-4300

Email: dschustack@ceocast.com


'/>"/>
SOURCE China Kangtai Cactus Biotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... The Texas Cord ... recently to the labor and delivery team at Women’s Hospital at Renaissance in Edinburg ... give birth at the hospital and decide to donate. , “Women’s Hospital at ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and ... drug safety and minimize the cost of development. In this webinar, sponsored by ... cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , ...
(Date:4/28/2017)... ... 28, 2017 , ... Bill Howe started his sewer and drain company in ... Howe joined the team, the Bill Howe brand was born and they began cultivating ... giving back to the San Diego community in which they worked, lived and were ...
(Date:4/28/2017)... ... 2017 , ... Researchers at Moffitt Cancer Center ... Data Hub in a sample of participants enrolled in an ongoing cancer quality-of-life ... solutions for the global scientific community. The company’s new CentrePoint Data Hub is ...
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec Solutions announced the publication ... a Microsoft Dynamics GP solution that integrates to their PointClickCare EHR software package. ... long-term care, Brooke Grove now has the capability to achieve its goal for ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
(Date:4/19/2017)... -- Cardiology devices segment is anticipated to reach the highest ... Devices segment is likely to create absolute $ opportunity of ... 2017. By the end of 2027, Cardiology Devices segment is ... Mn, expanding at a CAGR of 18.4% over the forecast ... Pacific reprocessed medical devices market in terms of ...
Breaking Medicine Technology: